2023
DOI: 10.1039/d3nj00973d
|View full text |Cite
|
Sign up to set email alerts
|

A study on optical properties of various hot drug molecules by 2020

Abstract: Advances in imaging technologies and imaging probes for in situ and real-time visualization of important analytes and biological events humans are now extending the applications of imaging further into drug...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…On the other hand, developing fluorescent and bio-activated small molecules is a potential strategy for cancer theranostics and research into novel drugs, which could monitor the enzyme activity level by fluorescence response and regulate the bio-activity of the cancer enzyme involved by the molecular activity mechanism. 109–114 Last but not least, the ultimate thrust of this research should be on clinical applications of these probes in imaging, diagnosis, and drug delivery systems based on the basic knowledge acquired from these studies.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, developing fluorescent and bio-activated small molecules is a potential strategy for cancer theranostics and research into novel drugs, which could monitor the enzyme activity level by fluorescence response and regulate the bio-activity of the cancer enzyme involved by the molecular activity mechanism. 109–114 Last but not least, the ultimate thrust of this research should be on clinical applications of these probes in imaging, diagnosis, and drug delivery systems based on the basic knowledge acquired from these studies.…”
Section: Discussionmentioning
confidence: 99%
“…6) with bright green fluorescence in HeLa cells. 185 In another work, we systematically studied the molecular properties of two marketed drugs ( alectinib and rilpivirine ) (Fig. 6) and further explored their photophysical luminous mechanisms, which provided a more theoretical basis for traceable drugs and promoted the development of integrated diagnosis and treatment.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%